Mid-Afternoon Market Update: Crude Oil Down 2%; Veritone Shares Jump
|Toward the end of trading Monday, the Dow traded down 0.34 percent to 24,306.62 while the NASDAQ climbed 0.40 percent to 6,997.05. The S&P also fell, dropping 0.25 percent to 2,626.56.
Leading and Lagging Sectors
Monday afternoon, the information technology shares climbed 1 percent. Meanwhile, top gainers in the sector included Xperi Corporation XPER 47.65% up 47 percent, and Veritone, Inc. VERI 21.67% up 22 percent.
In trading on Monday, energy shares fell 2 percent.
Top Headline
NutriSystem Inc. NTRI 28.19% confirmed Monday morning it has agreed to sell itself to Tivity Health Inc TVTY 31.68%, a provider of fitness and health improvement programs, in a cash and stock transaction.
Tivity will pay Nutrisystem shareholders $38.75 per share in cash in addition to 0.2141 Tivity Health shares for each share of Nutrisystem common stock. The transaction implies an enterprise value of $1.3 billion and an equity value of $1.4 billion, or around $47 per share. The deal implies a 30 percent premium based on the volume-weighted average price for Nutrisystem's stock over the past five trading sessions.
Equities Trading UP
Xperi Corporation XPER 47.65% shares got a boost, shooting up 47 percent to $18.82 after the company announced a settlement of all litigation against Samsung and reported a new patent license agreement between the two companies. Xperi also raised FY18 and Q4 billings guidance.
Shares of Nutrisystem, Inc. NTRI 28.19% shot up 28 percent to $43.79 after Tivity Health, Inc. TVTY 31.68% announced plans to acquire Nutrisystem for $47 per share in cash and stock.
Veritone, Inc. VERI 21.67% shares were also up, gaining 22 percent to $6.88 after receiving an acquisition offer from Apis Capital Management for $10.26 per share in cash.
Equities Trading DOWN
Tivity Health, Inc. TVTY 31.68% shares dropped 33 percent to $27.09 after the company announced plans to acquire Nutrisystem, Inc. NTRI 28.19% for $47 per share in cash and stock.
Shares of MacroGenics, Inc. MGNX 25.23% were down 23 percent to $12.58 after reporting partial clinical hold on MGD009 Phase 1 studies.
Axovant Sciences Ltd. AXON 28.06% was down, falling around 26 percent to $1.25 after the company disclosed that it did not meet its primary endpoint for its Phase 2 study of nelotanserin.
Commodities
In commodity news, oil traded down 2.03 percent to $51.54 while gold traded down 0.26 percent to $1,249.40.
Silver traded down 0.59 percent Monday to $14.61, while copper fell 1.36 percent to $2.722.
European shares closed lower today. The eurozone’s STOXX 600 fell 1.87 percent, the Spanish Ibex Index dropped 1.76 percent, while Italy’s FTSE MIB Index declined 1.77 percent. Meanwhile the German DAX declined 1.54 percent, and the French CAC 40 slipped 1.47 percent while U.K. shares fell 0.8 percent.
Economics
U.S. job openings increased to 7.08 million for October, from 6.96 million, according to the Labor Department's JOLTS report.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.